Menu Back toRedefining-the-Site-Investigator-s-Experience

DIA 2018 Global Annual Meeting

Redefining the Site Investigator's Experience

    Session Chair(s)
      Christine  Pierre, RN

      Christine Pierre, RN

      • President
      • Society for Clinical Research Sites, United States
    Knowledgeable site investigators are essential to conducting successful clinical trials. However, data suggest that administrative, financial, and logistical burdens associated with leading clinical trials are causing investigators to abandon clinical research after just one study (i.e “one-and-done”). Without a sufficient pool of experienced site investigators, US-based clinical trials are likely to become less efficient and more costly, ultimately threatening timely patient access to safe and effective therapies.
    This forum will discuss actionable, evidence-based recommendations for strengthening and growing the site investigator community. This, in turn, will help to ensure the long-term sustainability of a US clinical trials enterprise capable of meeting the needs of patients and care providers.
    Learning Objective : Describe factors that influence investigators’ decisions to leave or remain in clinical research practice; Facilitate an informed discussion of the challenges to, and strategies for, ensuring an adequate investigator workforce; Discuss practical, action-based recommendations that can support the engagement, training, and retention of qualified site investigators.
      Earl  Seltzer, MBA

      Bullsye! Hitting the Mark from Long Distance: Partnering with Sites to Better Plan for Study Conduct in Feasibility

      Earl Seltzer, MBA

      • Director, Global Feasibility-Site and Patient Access
      • Syneos Health, United States
      Lisa Bartoli Moneymaker

      Update on Redefining the Site Investigator Experience

      Lisa Bartoli Moneymaker

      • CTMS Process Architect and SIP Implementation Lead
      • Amgen Inc., United States